VeriMompalmitoyl tetrapeptide-50 hamilelikte güvenli mi?
No harmonised CLP classification (ECHA Annex VI), no SCCS or CIR reproductive/toxicity flags located, and no peer‑reviewed reproductive toxicity or human teratogenicity data identified in database searches (PubMed, PubChem, CosIng, ECHA dossiers). CIR/SCCS-style sources do not indicate reproductive hazard, so default hazard/mechanism scores are 0. Exposure from topical cosmetic use is expected to be negligible for reproductive systemic effect in adults.
Pregnancy-safe products containing palmitoyl tetrapeptide-50
Related ingredients
Frequently asked questions
- palmitoyl tetrapeptide-50 hamilelikte güvenli mi?
- No harmonised CLP classification (ECHA Annex VI), no SCCS or CIR reproductive/toxicity flags located, and no peer‑reviewed reproductive toxicity or human teratogenicity data identified in database searches (PubMed, PubChem, CosIng, ECHA dossiers). CIR/SCCS-style sources do not indicate reproductive hazard, so default hazard/mechanism scores are 0. Exposure from topical cosmetic use is expected to be negligible for reproductive systemic effect in adults.
- palmitoyl tetrapeptide-50 emzirirken güvenli mi?
- No evidence of reproductive or lactation-specific toxicity in available regulatory/peer‑reviewed sources (ECHA, PubMed, CosIng, EWG). Given lack of systemic toxicity data and expected low systemic absorption after topical use, breastfeeding hazard and mechanism are scored 0 and exposure is considered negligible for causing breastmilk-mediated effects.
- palmitoyl tetrapeptide-50 bebek cildi için güvenli mi?
- No infant-specific toxicity or developmental effects identified. Peptides (even palmitoylated) are relatively large molecules and literature/regulatory sources do not report reproductive or developmental toxicity, so hazard/mechanism remain 0. Because infant skin has higher permeability and surface-area-to-weight, exposure score is increased by +1 relative to adults (from negligible to low/measurable), although no data indicate systemic harm.
- VeriMom palmitoyl tetrapeptide-50 nasıl puanlıyor?
- VeriMom palmitoyl tetrapeptide-50'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte palmitoyl tetrapeptide-50 yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.